Exelixis continues to outperform Gilead by 19.3% year to date

Media coverage

• Title	Exelixis continues to outperform Gilead by 19.3% year to date
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	5/20/25
  Persons	George Poste

• Title	Exelixis continues to outperform Incyte by 41.8% year to date
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	5/20/25
  Persons	George Poste

• Title	Exelixis continues to outperform Regeneron by 50.5% year to date
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	5/20/25
  Persons	George Poste

• Title	Exelixis continues to outperform Vertex Pharmaceuticals by 24.8% year to date
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	5/20/25
  Persons	George Poste

• Title	The Long-Term Bullish Case For Exelixis
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	5/20/25
  Persons	George Poste